| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.24 | 7e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.22 | 2e-06 |